Suppr超能文献

新型潜在细胞毒性和抗肿瘤物质I. 比卡维林及其衍生物对某些肿瘤细胞的体外作用

New potential cytotoxic and antitumor substances I. In vitro effect of bikaverin and its derivatives on cells of certain tumors.

作者信息

Fuska J, Proksa B, Fusková A

出版信息

Neoplasma. 1975;22(3):335-8.

PMID:1172201
Abstract

Bikaverin and its derivatives have been found to affect precursor utilization of nucleic acid and protein synthesis in the cells of Ehrlich ascites carcinoma (EAC). Mainly the uridine incorporation into EAC cells was inhibited. This is in agreement with the known concept that anthraquinones, to which bikaverin may also be assigned, intervene into RNA synthesis. The substances followed exerted a cytotoxic effect on in vitro proliferating cells of the three studied tumors. The ED50 values found for cells of these tumors were: EAC 0.5 mug/ml; leukemia L 5178 1.4 mug/ml; sarcoma 37 4.2 mug/ml.

摘要

已发现比卡维林及其衍生物会影响艾氏腹水癌(EAC)细胞中核酸和蛋白质合成的前体利用。主要是尿苷掺入EAC细胞受到抑制。这与已知的概念一致,即比卡维林也可能归属的蒽醌类物质会干预RNA合成。随后这些物质对所研究的三种肿瘤的体外增殖细胞产生了细胞毒性作用。这些肿瘤细胞的半数有效剂量(ED50)值分别为:EAC 0.5微克/毫升;白血病L 5178 1.4微克/毫升;肉瘤37 4.2微克/毫升。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验